Shell Asset Management’s Immunomedics Inc IMMU Stock Holding History

Shell Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-12,431	Closed	-$1.06M	–	1483
2020 Q3	$1.06M	Hold	12,431	–	–	0.02%	443
2020 Q2	$441K	Sell	12,431 -149	-1%	-$4.36K	0.01%	719
2020 Q1	$170K	Sell	12,580 -191	-1%	-$3.21K	﹤0.01%	1043
2019 Q4	$270K	Sell	12,771 -290	-2%	-$5.12K	0.01%	1076
2019 Q3	$173K	Sell	13,061 -112	-0.9%	-$1.65K	﹤0.01%	1147
2019 Q2	$183K	Sell	13,173 -300	-2%	-$4.51K	﹤0.01%	1135
2019 Q1	$259K	Hold	13,473	–	–	0.01%	1065
2018 Q4	$192K	Sell	13,473 -1,100	-8%	-$21.8K	﹤0.01%	1043
2018 Q3	$304K	Buy	+14,573	New	+$345K	0.01%	1067

Shell Asset Management's IMMU Position: Q4 2020 in Review

Shell Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 12,431 shares — an estimated $1.06M sold.

Shell Asset Management first reported a position in IMMU in Q3 2018 and held it in 9 quarters. The position peaked at $1.06M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Shell Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Shell Asset Management sold 12,431 Immunomedics Inc shares in Q4 2020, an estimated $1.06M.
Shell Asset Management first reported a position in Immunomedics Inc in Q3 2018 and held it in 9 quarters.
Shell Asset Management's Immunomedics Inc position peaked at $1.06M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Shell Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.